COLLIER ALAN BRIAN (CEO) purchased 0.1% of their position (15K shares) of ENDONOVO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $46.30 — a small addition. The strongest form of insider conviction signal.
Common Stock
Shares
+2K
Price / share
$0.00
Trade value
$7.00
% of position
Common Stock
Shares
+1K
Price / share
$0.00
Trade value
$3.50
% of position
Common Stock
Shares
+2K
Price / share
$0.00
Trade value
$7.00
% of position
Common Stock
Shares
+2K
Price / share
$0.00
Trade value
$5.80
% of position
Common Stock
Shares
+2K
Price / share
$0.00
Trade value
$5.80
% of position
Common Stock
Shares
+2K
Price / share
$0.00
Trade value
$5.80
% of position
Common Stock
Shares
+2K
Price / share
$0.00
Trade value
$5.80
% of position
Common Stock
Shares
+2K
Price / share
$0.00
Trade value
$5.60
% of position
Net shares
+15K
Net value
$46.30
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/25/2019 | P · Purchase | +2K | $0.00 | $7.00 | 0.0% | 25.40M | 25.40M |
| Common Stock Direct | 11/27/2019 | P · Purchase | +1K | $0.00 | $3.50 | 0.0% | 25.40M | 25.40M |
| Common Stock Direct | 11/27/2019 | P · Purchase | +2K | $0.00 | $7.00 | 0.0% | 25.40M | 25.40M |
| Common Stock Direct | 11/29/2019 | P · Purchase | +2K | $0.00 | $5.80 | 0.0% | 25.40M | 25.40M |
| Common Stock Direct | 12/2/2019 | P · Purchase | +2K | $0.00 | $5.80 | 0.0% | 25.40M | 25.41M |
| Common Stock Direct | 12/4/2019 | P · Purchase | +2K | $0.00 | $5.80 | 0.0% | 25.41M | 25.41M |
| Common Stock Direct | 12/4/2019 | P · Purchase | +2K | $0.00 | $5.80 | 0.0% | 25.41M | 25.41M |
| Common Stock Direct | 12/5/2019 | P · Purchase | +2K | $0.00 | $5.60 | 0.0% | 25.41M | 25.41M |
| Total | +15K | $46.30 | ||||||